This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Generic Name
- Ultevursen
- DrugBank Accession Number
- DB17835
- Background
Ultevursen is a single-stranded RNA-based oligonucleotide targeting exon 13 of the USH2A gene that encodes usherin. It was developed by ProQR Therapeutics and is being investigated for the treatment of retinitis pigmentosa.
- Type
- Biotech
- Groups
- Investigational
- Biologic Classification
- Nucleic Acid Based Therapies
Oligonucleotides - Synonyms
- Not Available
- External IDs
- QR 421a
- QR-421
- QR-421a
- QR421a
- QRX-421
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 94AC8YWE3I
- CAS number
- 2642382-41-8
References
- General References
- Not Available
- External Links
- Not Available
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data2 Not Yet Recruiting Treatment Deaf Blind / Eye Diseases, Hereditary / Eye disorders congenital / Retinal Diseases / Retinitis Pigmentosa (RP) / Usher Syndrome Type 2 / Vision Disorders 1 somestatus stop reason just information to hide 2 Terminated Treatment Retinitis Pigmentosa (RP) / Usher Syndrome Type 2 1 somestatus stop reason just information to hide 2, 3 Terminated Treatment Deaf Blind / Eye Diseases / Eye Diseases, Hereditary / Eye disorders congenital / Retinal Diseases / Retinitis Pigmentosa (RP) / Usher Syndrome Type 2 / Vision Disorders 2 somestatus stop reason just information to hide 1, 2 Completed Treatment Deaf Blind / Eye Diseases / Eye Diseases, Hereditary / Eye disorders congenital / Retinal Diseases / Retinitis Pigmentosa (RP) / Usher Syndrome Type 2 / Vision Disorders 1 somestatus stop reason just information to hide
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at May 31, 2023 14:34 / Updated at July 18, 2023 22:59